GKOS · NYSE · Medical - Devices

Glaukos (GKOS)

Develops implantable glaucoma therapies and corneal cross-linking treatments.

$159.77
vs last close−0.09 (−0.06%)
  1. GKOS Stock Surges 67% Year to Date: What's Driving the Rally?

    Zacks Investment ResearchMarket move